Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Hospital Universitari Joan XXIII de Tarragona. | OTHER |
Not provided
Not provided
Not provided
Not provided
Endometriosis is a chronic inflammatory condition characterized by the presence of endometrium-like tissue outside the uterine cavity. It is estimated to affect approximately 10% of women of reproductive age and it is associated with chronic pelvic pain and infertility, among other symptoms.
Endometriosis involves complex changes in the body's cells and immune response. For this reason, the goal of this observational study is to characterize the functional, molecular, and immunological alterations in menstrual blood-derived stem cells (MenSCs) and differentiated decidual stromal cells in women with endometriosis; to validate these findings in endometrial tissue and endometriomas; and to establish their correlation with clinical parameters, with the aim of identifying key pathogenic mechanisms and potential therapeutic targets.
The main questions it aims to answer are:
Some participants will be asked to provide menstrual blood on a single day, while others will provide samples during the first five days of menstruation. Additionally, all participants will answer questionnaires about their diet, physical activity, stress, and pain levels. Therefore, the study does not involve the evaluation of a specific intervention on the participants.
The results will enable the identification of key altered mechanisms and potential therapeutic targets, thereby contributing to the development of more effective strategies for the diagnosis and treatment of the disease.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Endometriosis |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Menstrual blood-derived stem cells collection and in vitro characterization | Other | Menstrual-blood derived stem cells will be isolated from the menstrual blood of patients with endometriosis and healthy volunteers to be characterized in vitro. |
| Measure | Description | Time Frame |
|---|---|---|
| MenSCs proliferation rate | Evaluation of the expansion capacity of MenSCs from endometriosis patients vs. healthy controls using the MTT assay. | Through study completion (average of 3 years) |
| Phenotypic characterization of MenSCs | Evaluation of surface marker expression using flow cytometry to determine the phenotype of MenSCs from endometriosis patients and healthy controls. | Through study completion (average of 3 years). |
| MenSC chemotaxis | Assessment of the number of T-lymphocytes and monocytes capable of migrating through a transwell membrane under the stimuli of conditioned media from MenSCs obtained from endometriosis patients and healthy controls. | Through study completion (average of 3 years) |
| MenSC invasion capacity | Assessment of the number of MenSCs from endometriosis patients vs. healthy controls capable of degrading a Matrigel on a transwell membrane and migrating toward a chemoattractant. | Through study completion (average of 3 years) |
| Multilineage capacity of MenSCs | The differentiation potential of MenSCs from endometriosis patients vs. healthy controls towards osteocytes, chondrocytes and adipocytes will be assessed by using specific media. | Through study completion (average of 3 years) |
| Decidualitzation response to progesterone of the decidual cells differentiated from MenSCs from endometriosis patients and healthy volunteers | MenSCs will be cultured in presence of 8-Br-cAMP during 14 days, and the assessment of morphology and expression of decidual markers will be performed by RT-qPCR and ELISA assay. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Our study population consists of 40 women aged between 18 and 45, 20 of whom have been diagnosed with endometriosis and 20 of whom are healthy volunteers. Participants will be recruited from the Department of Gynecology and Obstetrics at the Hospital Universitari Joan XXIII in Tarragona (Spain) during routine gynecological check-ups. Healthy volunteers will be selected through individual matching with participants in the study group, considering relevant demographic and clinical variables such as age and ethnic group.
In addition, a sub-cohort of 10 women (5 per study group) will be selected from the main cohort to study in greater detail the intra-menstrual variations in the immunomodulatory properties of MenSCs. This sub-cohort will include participants who agree to provide menstrual blood samples from days 1 to 5 (both inclusive) to analyze dynamic changes in the cells obtained, while maintaining the same general inclusion and exclusion criteria as in the main study.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Dr. Francisco Algaba-Chueca | Contact | +34623966066 | francisco.algaba@urv.cat | |
| Dr. Victoria Linares-Vidal | Contact | +34977759374 | mvictoria.linares@urv.cat |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Universitat Rovira i Virgili. Facultat de Medicina i Ciències de la Salut | Active, not recruiting | Reus | Tarragona | 43201 | Spain |
Not provided
| ID | Term |
|---|---|
| D004715 | Endometriosis |
| ID | Term |
|---|---|
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Through study completion (average of 3 years). |
| Apoptosis resistance assessment of the decidual cells differentiated from MenSCs from endometriosis patients and healthy volunteers | Apoptosis resistance will be evaluated by Annexin V/PI flow cytometry following induction by TNFα. Additionally, the expression of key apoptotic mediators will be quantified using RT-qPCR and Western blot. | Through study completion (average of 3 years). |
| Cytokine profile of the secretome of MenSCs from endometriosis patients and healthy volunteers and their differentiated decidual cells. | The conditioned media will be assessed to determine the cytokines secreted using an ELISA assay. | Through study completion (average of 3 years). |
| Cytokine profile of the endometrial and endometrioma tissues | The levels of cytokines in the conditioned media from cultured explants will be assessed by ELISA assay. | Through study completion (average of 3 years). |
| Cytokine profile of the secretome of immune cells populations | The levels of cytokines in the conditioned media from lymphocytes and macrophages will be assessed by ELISA assay. | Through study completion (average of 3 years) |
| Cytokine profile of the peripheral blood plasma | The levels of cytokines in peripheral blood plasma from endometriosis patients and healthy volunteers will be determined by ELISA assay. | Through study completion (average of 3 years) |
| Gene expression profile of MenSCs from endometriosis patients and healthy volunteers and their differentiated decidual cells | Total RNA expression of targeted genes will be analyzed by RT-qPCR. | Through study completion (average of 3 years) |
| Gene expression profile of the endometrial and endometrioma tissues | Total RNA expression of targeted genes will be analyzed by RT-qPCR. | Through study completion (average of 3 years). |
| Gene expression profile of the immune cells populations | Total RNA expression of targeted genes will be analyzed by RT-qPCR. | Through study completion (average of 3 years) |
| Protein expression of MenSCs from endometriosis patients and healthy volunteers and their differentiated decidual cells | Analysis of the protein expression profile via Western Blot. | Through study completion (average of 3 years) |
| Protein expression in endometrial and endometrioma tissues | Analysis of the protein expression profile via Western Blot. | Through study completion (average of 3 years) |
| Protein expression in immune cells populations | Analysis of the protein expression profile via Western Blot. | Through study completion (average of 3 years) |
| T cells activation | T cells will be exposed to conditioned media from MenSCs from healthy volunteers and endometriosis patients. Afterwards, the levels of IL-10 and IFNy will be determined by ELISA assay. | Through study completion (average of 3 years) |
| T cells proliferation rate | T cells will be exposed to conditioned media from MenSCs from healthy volunteers and endometriosis patients. Afterwards, their proliferative capacity will be assessed by MTT assay. | Through study completion (average of 3 years) |
| Cytokine secretion profile of macrophages | The levels of cytokines in the supernatant of polarized macrophages after incubation with MenSC-derived conditioned media from endometriosis patients and healthy volunteers will be determined by ELISA assay. | Through study completion (average of 3 years) |
| Gene expression profile of macrophages | Total RNA expression of targeted genes will be analyzed by RT-qPCR. | Through study completion (average of 3 years) |
| Protein expression of macrophages | Analysis of the protein expression profile via Western Blot. | Through study completion (average of 3 years) |
| Phagocytic capacity of macrophages | Assessment of the macrophages' ability to engulf fluorescently labeled apoptotic bodies from MenSCs via flux cytometry and fluorescence microscopy. | Through study completion (average of 3 years) |
| Angiogenic potential of macrophages conditioned media | Evaluation of the ability of macrophage-derived conditioned media to induce tube formation (Matrigel) in Human Umbilical Vein Endothelial Cells (HUVECs). | Through study completion (average of 3 years) |
| Exploration of targeted interventions to reverse the pathological phenotype of MenSCs and macrophages derived from menstrual blood. | Signaling pathways and genes involved in the altered phenotype will be blocked and silenced, respectively, to evaluate if these actions reverse the cellular response to the levels of the healthy volunteers' cells. | Through study completion (average of 3 years). |
| Correlation of cellular, tissue and molecular findings with patients' clinical parameters. | The associations among the functional and immunological properties of MenSCs and macrophages, clinical parameters and dietary and behavioral habits will be stablished. These clinical parameters include endometriosis stage, pain and fertility status, and the extent and localization of the endometriosis foci. | Through study completion (average of 3 years). |
| Hospital Universitari Joan XXIII | Recruiting | Tarragona | Tarragona | 43005 | Spain |
|
| D000091662 | Genital Diseases |